Last reviewed · How we verify
cisplatin-fluorouracil chemotherapy — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
cisplatin-fluorouracil chemotherapy (cisplatin-fluorouracil chemotherapy) — Simcere Pharmaceutical Co., Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| cisplatin-fluorouracil chemotherapy TARGET | cisplatin-fluorouracil chemotherapy | Simcere Pharmaceutical Co., Ltd | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- cisplatin-fluorouracil chemotherapy CI watch — RSS
- cisplatin-fluorouracil chemotherapy CI watch — Atom
- cisplatin-fluorouracil chemotherapy CI watch — JSON
- cisplatin-fluorouracil chemotherapy alone — RSS
Cite this brief
Drug Landscape (2026). cisplatin-fluorouracil chemotherapy — Competitive Intelligence Brief. https://druglandscape.com/ci/cisplatin-fluorouracil-chemotherapy. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab